Receiving IP is only the beginning. Explore how the first patient visit can expose gaps in dispensing, delegation, IRT, documentation, and site readiness.
- One IP Receipt Problem Is An Exception. Four Is A Process.
- Root Causes, Part 4: Why Clinical Supply Teams Are Always Firefighting
- Your IP Shipment Arrives At 07:00. Who Opens The Box?
- Segregation Of Duties: Drug Accountability Needs Three Separate Roles
- When Clinical Demand Becomes A Supply Plan
- Before The Excursion: The Governance Decisions That Should Already Be Made
- Clinical Trial Supply Chains Are Moving From Planning For Stability To Preparing For Uncertainty
- Root Causes, Part 3: The Hidden Cost of Clinical Supply Work That Doesn't Move Trials Forward
ON-DEMAND WEBINARS
This webinar presents the ultimate guide to scenario planning through modern technology as a way to inform clinical supply decisions.
Experts take you through the entire selection process for primary packaging components for lyophilization and provide aspects to consider for all relevant attributes.
Want to know more about the growth and expansion of IRT in the decentralized trial space? Witness how IRT is being used to support direct-to-patient delivery in this hybrid trial case study.
Consider these strategies when anticipating and mitigating disruptions, and how future innovations and trends will continue to shape the logistics industry.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1189150676-Medicinal_Marijuana_Cannabis_ControlledSubstance]( "Controlled Substances In Clinical Trials")
Controlled Substances In Clinical TrialsHandling controlled substances presents layers of complexity. Partnering with an experienced CDMO is essential for managing scheduled materials during clinical studies.
-
![iStock-1183744765-map]( "Managing Complex Global Drug Distribution And Expiry")
Managing Complex Global Drug Distribution And ExpiryA global top-ten pharma company sponsored a complex, 8-year Phase III trial across 43 countries. As costs mounted and supplies waned, it realized the trial could be better managed if outsourced.
-
![Ampoule Aseptic Filling GettyImages-1490244818]( "Advantages Of Robotic Aseptic Processing")
Advantages Of Robotic Aseptic ProcessingExamine the robotic technologies poised to increase manufacturing flexibility and efficiency while minimizing risk when bringing biologics to market.
-
![Digital supply chain mangement, global logistic-GettyImages-2250495598]( "Leveraging A Demand-Led Clinical Supply Model For Program-Level Product Pooling")
Leveraging A Demand-Led Clinical Supply Model For Program-Level Product PoolingSee how a global biopharmaceutical company was able to address inefficiencies and reduce waste within the clinical supply chain for a high-value therapy that faced strong demand but limited supply.
-
![cell-gene-therapy-GettyImages-2157300524]( "FastChain®: A Solution For Made-To-Order Gene Replacement Therapy Study")
FastChain®: A Solution For Made-To-Order Gene Replacement Therapy StudyAdopt a demand-led clinical supply strategy to reduce waste, optimize limited product supply, and accelerate patient access across global clinical trials.
-
![GettyImages-1467240751 patient doctor]( "Delivering Apheresis Treatment From The USA To The UK Within 24 Hours")
Delivering Apheresis Treatment From The USA To The UK Within 24 HoursThe goal was to perform next-day collection of temperature-sensitive tumor material for an urgent patient treatment. A flexible mitigation strategy was essential to manage short turnaround.
-
![GettyImages-1254705026 clinical supplies]( "A Supply Chain Management Solution Designed for Clinical Research")
A Supply Chain Management Solution Designed for Clinical ResearchIn this use case, follow along the clinical supplies management journey to learn how GxP Inventory replaces fragmented, spreadsheet-based processes to optimize visibility, traceability, and compliance.
-
![electronic-medical-technology-GettyImages-1204743045]( "Benefits Of Electronic Labels: Investigational Medicinal Products")
Benefits Of Electronic Labels: Investigational Medicinal ProductsWhen a new therapeutic drug, medical device, vaccine, or other investigational medicinal product (IMP) is developed, learn why a label must be on its packaging that provides relevant and important information.
-
![Quality Management GettyImages-1336716297]( "Quality Assured: Bringing Life-Changing Therapies To Patients")
Quality Assured: Bringing Life-Changing Therapies To PatientsBiopharmaceutical drug development remains a key trend, demanding specific expertise and capabilities when it comes to quality assurance. Explore four trends that matter in biologics for clinical trial supply.
-
![Pharmaceutical-Drug-Manufacturing-GettyImages-1405788565]( "Specializing In Small And Early-Stage Partners, Not Just Small Batches")
Specializing In Small And Early-Stage Partners, Not Just Small BatchesMany small and/or early-stage companies are not aware of the need, or the possibility, of finding a CDMO that specializes in meeting their specific requirements.
- Root Causes, Part 4: Why Clinical Supply Teams Are Always Firefighting
- Root Causes, Part 3: The Hidden Cost of Clinical Supply Work That Doesn't Move Trials Forward
- Root Causes, Part 2: The Translation Problem Behind Clinical Trial Execution
- Root Causes, Part 1: When Trial Design Locks In Supply Risk
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
